Publication: Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia
dc.contributor.author | Albasanz-Puig, Adaia | |
dc.contributor.author | Durà-Miralles, Xavier | |
dc.contributor.author | Laporte-Amargós, Júlia | |
dc.contributor.author | Mussetti, Alberto | |
dc.contributor.author | Ruiz-Camps, Isabel | |
dc.contributor.author | Puerta-Alcalde, Pedro | |
dc.contributor.author | Abdala, Edson | |
dc.contributor.author | Oltolini, Chiara | |
dc.contributor.author | Akova, Murat | |
dc.contributor.author | Montejo ,José Miguel | |
dc.contributor.author | Malgorzata, Mikulska | |
dc.contributor.author | Martín-Dávila, Pilar | |
dc.contributor.author | Herrera, Fabián | |
dc.contributor.author | Gasch, Oriol | |
dc.contributor.author | Drgona, Lubos | |
dc.contributor.author | Paz Morales, Hugo Manuel | |
dc.contributor.author | Brunel, Anne-Sophie | |
dc.contributor.author | García, Estefanía | |
dc.contributor.author | Isler, Burcu | |
dc.contributor.author | Kern, Winfried V. | |
dc.contributor.author | Retamar-Gentil, Pilar | |
dc.contributor.author | Aguado, José María | |
dc.contributor.author | Montero, Milagros | |
dc.contributor.author | Kanj, Souha S. | |
dc.contributor.author | Sipahi, Oguz R. | |
dc.contributor.author | Calik, Sebnem | |
dc.contributor.author | Márquez-Gómez, Ignacio | |
dc.contributor.author | Marín, Jorge I. | |
dc.contributor.author | Gomes, Marisa Z.R. | |
dc.contributor.author | Hemmati, Philipp | |
dc.contributor.author | Araos Bralic, Rafael Ignacio | |
dc.contributor.author | Peghin, Magdalena | |
dc.contributor.author | Pozo, José Luis del | |
dc.contributor.author | Yáñez, Lucrecia | |
dc.contributor.author | Tilley, Robert | |
dc.contributor.author | Manzur, Adriana | |
dc.contributor.author | Novo, Andres | |
dc.contributor.author | Pallarès, Natàlia | |
dc.contributor.author | Bergas, Alba | |
dc.contributor.author | Carratalà, Jordi | |
dc.contributor.author | Gudiol, Carlota | |
dc.contributor.author | The Ironic Study Group | |
dc.date.accessioned | 2023-12-05T20:55:48Z | |
dc.date.available | 2023-12-05T20:55:48Z | |
dc.date.issued | 2022 | |
dc.description.abstract | To assess the effect of combination antibiotic empirical therapy on 30-day case-fatality rate in neutropenic cancer patients with Pseudomonas aeruginosa (PA) bacteremic pneumonia. This was a multinational, retrospective cohort study of neutropenic onco-hematological patients with PA bloodstream infection (BSI) (2006−2018). The effect of appropriate empirical combination therapy, appropriate monotherapy and inappropriate empirical antibiotic therapy [IEAT] on 30-day case-fatality was assessed only in patients with PA bacteremic pneumonia. Among 1017 PA BSI episodes, pneumonia was the source of BSI in 294 (28.9%). Among those, 52 (17.7%) were caused by a multidrug-resistant (MDR) strain and 68 (23.1%) received IEAT, mainly when the infection was caused by an MDR strain [38/52 (73.1%) vs. 30/242 (12.4%); p < 0.001]. The 30-day case-fatality rate was higher in patients with PA bacteremic pneumonia than in those with PA BSI from other sources (55.1% vs. 31.4%; p < 0.001). IEAT was associated with increased 30-day case-fatality (aHR 1.44 [95%CI 1.01−2.03]; p = 0.042), whereas the use of appropriate combination empirical treatment was independently associated with improved survival (aHR 0.46 [95%CI 0.27−0.78]; p = 0.004). Appropriate empirical monotherapy was not associated with improved overall survival (aHR 1.25 [95%CI 0.76−2.05]; p = 0.39). Combination antibiotic empirical therapy should be administered promptly in febrile neutropenic patients with suspected pneumonia as the source of infection. | |
dc.description.version | Versión publicada | |
dc.format.extent | 14 p. | |
dc.identifier.citation | Albasanz-Puig, A.; Durà-Miralles, X.; Laporte-Amargós, J.; Mussetti, A.; Ruiz-Camps, I.; Puerta-Alcalde, P.; Abdala, E.; Oltolini, C.; Akova, M.; Montejo, J.M.; et al. Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia. Microorganisms 2022, 10, 733. https://doi.org/10.3390/ microorganisms10040733 | |
dc.identifier.doi | https://doi.org/10.3390/ microorganisms10040733 | |
dc.identifier.uri | https://repositorio.udd.cl/handle/11447/8139 | |
dc.language.iso | en | |
dc.subject | Pseudomonas aeruginosa | |
dc.subject | Bloodstream infection | |
dc.subject | Pneumonia | |
dc.subject | Septic shock | |
dc.subject | Neutropenia | |
dc.title | Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia | |
dc.type | Article | |
dcterms.abstract | Acceso abierto | |
dcterms.source | Microorganisms | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | 69e40056-7a55-41b3-8a65-05aace0e07e3 | |
relation.isAuthorOfPublication.latestForDiscovery | 69e40056-7a55-41b3-8a65-05aace0e07e3 |